Releases
GOVXW
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Geovax Labs Inc (GOVXW) stock and general news. This information may help you make smarter investment decisions.
About GOVXW
GeoVax Labs, Inc. (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapies and vaccines against cancers and infectious diseases using a vector vaccine platform (Modified Vaccinia Ankara-Virus Like Particle or GV-MVA-VLP). It is focused on developing a vaccine for prevention of coronavirus (COVID-19) infection. The GV-MVA-VLP platform provides design and test vaccine to candidates, which differ through the inclusion of multiple SARS-CoV-2 proteins that are presented to the immune system as virus-like particles (VLPs). The Company's development programs are focused on preventive vaccines against hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa fever), Zika virus and malaria; preventive and therapeutic vaccines against Human Immunodeficiency Virus (HIV); as well as immunotherapies for solid tumor cancers. The Company is developing vaccines and immunotherapies for prevention or treatment of infectious diseases and cancer.